“[O]ne thing I’ve learned from working on HIV/AIDS my entire political career — we are far better united than divided,” Rep. Barbara Lee (D-Calif.) writes in a Politico opinion piece, noting examples of bipartisan legislation that “help to slow the rate of infections and reduce the number of deaths from AIDS.” She continues, “We can put into place the policies that can help end AIDS. Even in a time of fiscal uncertainty, we have the resources. We just have to be smart about it, and that means responding to the reality of HIV and not the luxury of our political comfort.” Lee writes, “Worldwide, we have to maximize our efficiency and build programs that make sense,” including integrating family planning, maternal health, and HIV services and “respond[ing] to the needs expressed by key populations, including men who have sex with men, sex workers, and people who inject drugs.” She says, “As long as we are supporting laws that limit comprehensive sex education, deny federal funding for syringe exchange services, or criminalize people living with HIV for consensual sex, biting and spitting, we are allowing HIV to thrive.”
“HIV is the leading cause of death of women of reproductive age,” and without HIV, “maternal mortality worldwide would be 20 percent lower,” Lucy Chesire, executive director and secretary to the Board of the TB ACTION Group, writes in the Huffington Post’s “The Big Push” blog. She says that women “often face barriers accessing HIV treatment and care,” adding she recently “was struck with the significant role the Global Fund [to Fight AIDS, Tuberculosis and Malaria] has played in reducing women’s barriers to treatment.”
Leading up to World AIDS Day on December 1, the AIDS.gov blog published several pieces discussing progress in reaching the goal of an AIDS-free generation. The pieces are summarized below.
In the Center for Strategic & International Studies’ (CSIS) “Smart Global Health” blog, Todd Summers, senior adviser at the CSIS Global Health Policy Center, reviews the Global Fund to Fight AIDS, Tuberculosis and Malaria’s old rounds-based grant system that the Global Fund Board recently agreed to replace with a new funding model “that’s designed to be flexible, focused, and fast,” he says. Summers describes some of the shortcomings of the old model, outlines the “[c]ore attributes” of the new model, and writes, “Many other important aspects of the new funding model remain to be worked out, and some larger questions remain. I’ll try to highlight some of these in upcoming blogs” (11/26).
The “grand experiment” of the Affordable Medicines Facility-malaria (AMFm) — a pilot program that aims to get artemisinin-based combination therapies (ACTs) into rural areas of several African nations — “seems likely to end, its successes underrated and potential improvements not yet explored,” a Nature editorial says. In October, “an independent evaluation found that it had performed remarkably well on the main benchmarks of success, increasing the number of outlets stocking ACTs and lowering prices,” but last week “the Global Fund to Fight AIDS, Tuberculosis and Malaria decided to end the AMFm as a stand-alone program, by integrating it into the fund’s core system for awarding malaria-control grants to countries,” the editorial notes, adding, “This integration probably spells the end for AMFm, because there will be no new money for the program after the end of next year.”
The Global Fund to Fight AIDS, Tuberculosis and Malaria Board recently made several decisions that will affect the future of the organization, including appointing former U.S. Global AIDS Coordinator Ambassador Mark Dybul as executive director and adopting a new funding model, Nature reports in an article examining the history and future of the Fund. “It has been a rough couple of years for the Global Fund,” but “[l]ast week’s appointment of Mark Dybul as executive director could signal a fresh start, and has been broadly welcomed,” Nature writes (Butler, 11/22). “As [Dybul] begins his four-year term in early February 2013, current Fund General Manager Gabriel Jaramillo will transition out of his position,” PlusNews reports, noting, “That position, created to guide the Fund through reforms proposed by a 2011 high-level review panel at a time of low donor confidence, will disappear.”
Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Monday published Issue 202 of its “Global Fund Observer.” Among other articles, the issue features an article on the selection of Ambassador Mark Dybul as the next Global Fund executive director; an article summarizing “the main decisions made by the Global Fund Board at its 28th meeting in Geneva on 14-15 November 2012”; and an article on the Global Fund Board’s approval of a new funding model (11/16).
Following the appointment of Ambassador Mark Dybul to be the next executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, as well as the Global Fund Board’s adoption of a new funding model, German Development Minister Dirk Niebel released his government’s next payment to the Global Fund in the amount of 100 million euros ($128 million), according to a press release from the German Federal Ministry for Economic Cooperation and Development. With the release of funds, the total contribution of the German government to the Global Fund in 2012 is 200 million euros ($256 million), the press release notes (11/16).
Noting the Global Fund to Fight AIDS, Tuberculosis and Malaria met last week to discuss progress in fighting the three diseases, Lucy Chesire, executive director and secretary to the board of the TB ACTION Group, interviews Lucica Ditiu, executive secretary of the Stop TB Partnership, about the global response to tuberculosis (TB) in the Huffington Post’s “The Big Push” blog. In the blog, Ditiu summarizes the state of the global TB response, discusses the emergence of multidrug-resistant TB (MDR-TB), and addresses the Global Fund’s role in the response to TB and the future of these efforts. “The Global Fund has an ambitious strategy that includes important milestones for anti-TB efforts,” Ditiu said, adding, “The international community must find a way to fund that strategy and to ensure that resources are allocated in a way that achieves the greatest good for the greatest number of people,” according to the blog (11/16).
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria on Thursday named as its new Executive Director Ambassador Mark Dybul, who helped create and then lead PEPFAR under former President George W. Bush, Intellectual Property Watch reports (Hermann, 11/15). According to the New York Times, “[h]e is respected by many AIDS activists in the United States, though there is some lingering controversy about his time in the Bush administration related to abstinence policies and anti-prostitution pledges imposed by conservative lawmakers as well as concerning strict licensing requirements for generic drugs” (McNeil, 11/15). The Financial Times reports Dybul said, “The most important thing is to look forward, not to the past. The U.S. funded more condoms than all other sources and 90 percent of all antiretrovirals are generics.” The newspaper notes, “Dybul’s appointment from a shortlist of four was adopted by the fund’s 26-strong board — composed of donor and recipient countries, non-governmental organizations, and business representatives — with just two abstentions, including France” (Jack, 11/15).